News Daily News Despite COVID-19, Heart Disease Remains Top US Killer: AHA Michael O'Riordan January 28, 2021
News Daily News Vitamin D, Calcium, Other Vitamins, and Supplements Do Not Prevent CVD Michael O'Riordan January 25, 2021
News Daily News FDA Approves Vericiguat for High-risk Patients With HF Michael O'Riordan January 20, 2021
News Daily News REPLACE COVID Bolsters Advice to Continue RAAS Inhibitors in COVID-19 Patients Todd Neale January 13, 2021
News Daily News Fewer Diagnostic Tests, Higher CV Mortality During COVID-19 Pandemic Michael O'Riordan January 12, 2021
News Daily News ACC’s HFrEF Update Includes ARNI, SGLT2 Inhibitor Trials Plus Tips for Care L.A. McKeown January 11, 2021
News Daily News AHA’s 2020 Top 10: ISCHEMIA, HCM, Early A-fib Intervention, and More Shelley Wood December 17, 2020
News Daily News Knowing Comorbidities, Medication Use May Save Lives in COVID-19 Michael O'Riordan December 15, 2020
News Features Tragedy as Catalyst: How COVID-19 May Transform Clinical Research for Good Todd Neale December 14, 2020
News Features Too Easy to Misconstrue: Is It Time to Ditch Periprocedural MI? Michael O'Riordan December 02, 2020
News Conference News AHA 2020 Simple Tech Empowers HF Patients, Boosting Health: EPIC-HF and MyROAD L.A. McKeown November 18, 2020
News Conference News AHA 2020 Sotagliflozin Scores Wins in SCORED and SOLOIST-WHF Trials Michael O'Riordan November 17, 2020
News Conference News AHA 2020 INVESTED: No Added CV Benefit From High-Dose Flu Vaccine Todd Neale November 17, 2020
News Conference News AHA 2020 OMEMI: Omega-3 Fatty Acids No Help in Elderly MI Patients Todd Neale November 15, 2020
News Conference News AHA 2020 One Pill to Treat Them All: Polycap Strategy Sees Success in TIPS-3 Michael O'Riordan November 13, 2020
News Conference News AHA 2020 Statin Benefits Confirmed in Elderly, Along With Harmful Effects of High Cholesterol Michael O'Riordan November 12, 2020
News Daily News CMS Weighs Medicare Coverage at the Time of FDA Approval for Breakthrough Devices Michael O'Riordan October 30, 2020